Discriminant Ability of the Shock Index, Modified Shock Index, and Reverse Shock Index Multiplied by the Glasgow Coma Scale on Mortality in Adult Trauma Patients: A PATOS Study

We evaluated a cohort of adult trauma patients transported to emergency departments. The first vital signs were used to calculate the SI, MSI, and rSIG. The areas under the receiver operating characteristic curves (AUROCs) and test results were used to compare the discriminant performance of the indices on short-term mortality and poor functional outcome. A subgroup analysis of geriatric patients, traumatic brain injury, penetrating injury, and non-penetrating injury was performed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Trauma Morality Pathologic Processes Pathological Conditions, Signs and Symptoms Shock Shock, Traumatic Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients (≥18 years) EMS-transported from January 2016 to December 2020

Exclusion criteria

Patients with missing entries of age, sex, triage, SBP, DBP, HR, or GCS were excluded.
Entries with missing records of in-hospital mortality or 30-day mortality were excluded from the short-term mortality cohort analyses.
Patients without a Modified Rankin Scale (MRS) record at discharge were excluded from the functional outcome cohort analyses.

Treatment and study plan

Observational

Other

Observational

Primary outcomes

Discriminant power of SI, MSI, and rSIG on short-term mortality for adult traumatic patients

Time frame: 30 days

AUROC in associated with short-term mortality with SI, MSI, rSIG

Secondary outcomes

Discriminant power of SI, MSI, and rSIG on functional outcome for adult traumatic patients

Time frame: We defined no symptoms, no significant disability, slight disability, and moderate disability (MRS 0-3) as favorable functional outcomes and moderately severe disability, severe disability, and death (MRS 4-6) as poor functional outcomes

AUROC in associated with functional outcome with SI, MSI, rSIG

Sponsors and collaborators

Lead sponsor

Mackay Memorial Hospital

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2020
Study completion: 2020
First posted: Sep 22, 2022
Registry last updated: Sep 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed